Immunotherapy as a Future Treatment for Relapsed and Metastatic Primary Pulmonary Sarcomas

Journal Title: Journal of Cancer and Tumor International - Year 2016, Vol 3, Issue 4

Abstract

Primary pulmonary sarcomas (PPS) are aggressive tumors that are ideally treated with complete surgical resection, although seldom possible. Chemotherapy and radiotherapy have proven to be inadequate as second-line in the majority of cases, requiring investigation into novel approaches to treatment. Due to the high rate of recurrence and advanced disease progression, immunotherapy is a future treatment modality that must be investigated in order to provide better prognosis. Studies predominantly focus on other soft tissue malignancies such as osteosarcoma, and thus research pertaining to PPS is limited.

Authors and Affiliations

Vasa Jevremovic, Alex Agelidis

Keywords

Related Articles

Complex of Small Non-coding RNAs piR-30074 and Antago-miR-155 and miR-125b with DDMC Carrier Transforms Girardi Heart Cells into CD4+ Cells

Girardi heart cells are cell culture of right atrial cells contaminated with HeLa cervical adenocarcinoma cells. The combined cells have genotypic characteristics of cervical cancer. In this study, was investigated influ...

Kolaviron an Active Biflavonoid of Garcinia kola Extract Prevent 1,2-dimethylhydrazine Induced Oxidative Stress and Lipid Peroxidation in the Initiation Phase of Colon Carcinogenesis in Wistar Rats

Colon cancer is steadily increasing in Africa with high mortality and it is a pathological consequence of persistent oxidative stress. Kolaviron an active biflavonoid, has been shown to possess antioxidant, anti-lipid pe...

The Relationship between Single Nucleotide Polymorphisms of Gene XRCC1 and Toxicity Induced Radiation in Patients with Head and Neck Cancer

Aims: The head and neck cancer is one of the most common types and their treatment brings complications such as dermatitis, mucositis and dysphagia. Studies of genetic variations of patients are those that enable the ide...

Socioeconomic and Age-incidence of Breast Cancer: Modeling Using Artificial Intelligence Technique

Purpose: The majority of women presenting with breast cancer it are not possible to identify specific risk factors. Age is the major factor on breast cancer incidence. Also, poverty status can be classified. Because of t...

Evaluation of Efficacy of Gefinitib in Comparison with Chemotherapy in Patients with Non-Small Cell Lung Carcinoma from India

Aim: Tyrosine kinase inhibitors (TKIs) are a new class of drugs that are proven to be more efficacious than chemotherapy in certain cancers including lung cancer. However, the efficacy of TKIs may vary in different globa...

Download PDF file
  • EP ID EP243369
  • DOI 10.9734/JCTI/2016/26676
  • Views 102
  • Downloads 0

How To Cite

Vasa Jevremovic, Alex Agelidis (2016). Immunotherapy as a Future Treatment for Relapsed and Metastatic Primary Pulmonary Sarcomas. Journal of Cancer and Tumor International, 3(4), 1-6. https://europub.co.uk./articles/-A-243369